Gene · 58484
Papers3,844
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 3,844
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signature for Prostate Cancer Based on Autophagy-Related Genes and a Nomogram for Quantitative Risk Stratification. | Dis Markers | 2022 | 35860692 | PubTator, text mining | PubMed |
| LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization. | Front Neurosci | 2022 | 35860297 | PubTator, text mining | PubMed |
| Composite immune marker scores associated with severe mental disorders and illness course. | Brain Behav Immun Health | 2022 | 35856063 | PubTator, text mining | PubMed |
| Identification of a Novel Pyroptosis-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Skin Cutaneous Melanoma. | Int J Gen Med | 2022 | 35855761 | PubTator, text mining | PubMed |
| Rare mutations in NLRP3 and NLRP12 associated with familial cold autoinflammatory syndrome: two Chinese pedigrees. | Clin Rheumatol | 2022 | 35852776 | PubTator, text mining | PubMed |
| Caspase-1-driven neutrophil pyroptosis and its role in host susceptibility to Pseudomonas aeruginosa. | PLoS Pathog | 2022 | 35849616 | PubTator, text mining | PubMed |
| Reprogramming Macrophage Metabolism and its Effect on NLRP3 Inflammasome Activation in Sepsis. | Front Mol Biosci | 2022 | 35847986 | PubTator, text mining | PubMed |
| Think Beyond Particle Cytotoxicity: When Self-Cellular Components Released After Immunogenic Cell Death Explain Chronic Disease Development. | Front Toxicol | 2022 | 35846433 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer. | Front Genet | 2022 | 35846123 | PubTator, text mining | PubMed |
| A Predictive Model Based on Pyroptosis-Related Gene Features Can Effectively Predict Clear Cell Renal Cell Carcinoma Prognosis and May Be an Underlying Target for Immunotherapy. | Dis Markers | 2022 | 35845137 | PubTator, text mining | PubMed |
| Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis. | J Inflamm Res | 2022 | 35845090 | PubTator, text mining | PubMed |
| PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement? | Pediatr Rheumatol Online J | 2022 | 35840971 | PubTator, text mining | PubMed |
| An Evidence-Based Guideline Improves Outcomes for Patients With Hemophagocytic Lymphohistiocytosis and Macrophage Activation Syndrome. | J Rheumatol | 2022 | 35840156 | PubTator, text mining | PubMed |
| Prognostic prediction of systemic immune-inflammation status for patients with colorectal cancer: a novel pyroptosis-related model. | World J Surg Oncol | 2022 | 35836259 | PubTator, text mining | PubMed |
| Spotlight on pyroptosis: role in pathogenesis and therapeutic potential of ocular diseases. | J Neuroinflammation | 2022 | 35836195 | PubTator, text mining | PubMed |
| Circ_0000181 regulates miR-667-5p/NLRC4 axis to promote pyroptosis progression in diabetic nephropathy. | Sci Rep | 2022 | 35835791 | PubTator, text mining | PubMed |
| Role of NLRP3 Inflammasome in Rheumatoid Arthritis. | Front Immunol | 2022 | 35833125 | PubTator, text mining | PubMed |
| Inflammasome activation: from molecular mechanisms to autoinflammation. | Clin Transl Immunology | 2022 | 35832835 | PubTator, text mining | PubMed |
| Diverse Control Mechanisms of the Interleukin-1 Cytokine Family. | Front Cell Dev Biol | 2022 | 35832789 | PubTator, text mining | PubMed |
| Pyroptosis in inflammation-related respiratory disease. | J Physiol Biochem | 2022 | 35819638 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58484/papers?page=52